Laura Kovanda

Also affiliated with Astellas Pharma (China), Astellas Pharma (United States)

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 1 paper. Top paper: “1699. Safety and Outcomes of Isavuconazonium Sulfate for the Treatment of Invasive Aspergillosis or Invasive Mucormycosis in Pediatric Patients”.

1699. Safety and Outcomes of Isavuconazonium Sulfate for the Treatment of Invasive Aspergillosis or Invasive Mucormycosis in Pediatric Patients

Open Forum Infectious Diseases(2023)10.1093/ofid/ofad500.1532

N/A

0DataRank · unranked

3 citations

Heidi Segers, Jaime G. Deville, William J. Muller, Ángela Manzanares, Michael Neely +12 more